Clinical Trial Update: Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation

View source ↗

Summary

A real-world data study sponsored by Novartis to collect how secukinumab is used in adults with moderate to severe hidradenitis suppurativa in the Russian Feder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hidradenitis Suppurativa | Status: ACTIVE_NOT_RECRUITING